Product testing

Quorum Review IRB and Kinetiq Leadership Participate in Multiple Clinical Research Initiatives

Retrieved on: 
Tuesday, May 8, 2018
Health, Clinical research, Pharmaceutical industry, Clinical trial, Design of experiments, Drug discovery, Product testing, Clinical trials

SEATTLE, May 8, 2018 /PRNewswire/ --Leadership from Quorum Review IRB and Kinetiq , the consulting and technology division of Quorum, have been invited, elected, or appointed to several key positions with clinical research initiatives, national trade organizations, and in respected academia.

Key Points: 
  • SEATTLE, May 8, 2018 /PRNewswire/ --Leadership from Quorum Review IRB and Kinetiq , the consulting and technology division of Quorum, have been invited, elected, or appointed to several key positions with clinical research initiatives, national trade organizations, and in respected academia.
  • "We are proud and excited to be involved with these reputable organizations that positively impact the clinical research community," says Quorum CEO Cami Gearhart.
  • "The pursuit of our mission supports these efforts and we appreciate that we are recognized as clinical research thought leaders."
  • He also sits on the steering committee for Harvard's Multi-Regional Clinical Trials ( MRCT ) Center and is a Global Impact Partner representative for the Society for Clinical Research Sites ( SCRS ).

CANbridge Life Sciences Appoints Vice President of Clinical Development and Medical Affairs and Director of Quality Assurance

Retrieved on: 
Monday, May 7, 2018
Health, Pharmaceutical industry, Clinical research, Clinical trial, Design of experiments, Drug discovery, Product testing, Sanofi

BEIJING, May 7, 2018 /PRNewswire/ -- CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it has filled two key operational positions: Vice President of Clinical Development and Medical Affairs and Director of Quality Assurance.

Key Points: 
  • BEIJING, May 7, 2018 /PRNewswire/ -- CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it has filled two key operational positions: Vice President of Clinical Development and Medical Affairs and Director of Quality Assurance.
  • Annie Teng, MD, is joining the company today as VP of Clinical Development and Medical Affairs and Janny Wang started as Director of Quality Assurance on April 9th.
  • Both are new positions, as CANbridge deepens its operational team as a commercial company with clinical trials.
  • Most recently, she was Head of Biology & Early Development at Sanofi, after having served for seven years there as Medical Director, Specialty Care.

New Findings on Oversight Effectiveness Released at Clinical Trial Innovation Summit

Retrieved on: 
Monday, May 7, 2018
Health, Clinical research, Pharmaceutical industry, Clinical trial, Design of experiments, Drug discovery, Product testing, Clinical, Tufts University

BOSTON, May 7, 2018 /PRNewswire/ -- Clinical Trial Innovation Summit-Booth #306Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, today announced that initial results from a new Tufts Center for the Study of Drug Development (CSDD) survey of global clinical executives will be discussed at the Clinical Trial Innovation Summit 2018 in Boston, on May 8th.

Key Points: 
  • BOSTON, May 7, 2018 /PRNewswire/ -- Clinical Trial Innovation Summit-Booth #306Comprehend Systems, Inc., the leader in Clinical Intelligence solutions, today announced that initial results from a new Tufts Center for the Study of Drug Development (CSDD) survey of global clinical executives will be discussed at the Clinical Trial Innovation Summit 2018 in Boston, on May 8th.
  • Beth Harper, a consultant who collaborated with the Tufts CSDD on this research, will present the findings that include effectiveness, or lack thereof, of various outsourcing models and program objectives.
  • Joining Beth in the presentation is Rick Morrison, President of Comprehend Systems, as primary sponsor of the research.
  • Clinical Trial Innovation Summit 2018, Aloft Boston Seaport Hotel
    "This research is key to both Sponsors and CRO partners as they mature their Oversight programs and focus," said Beth Harper.

ANSI Releases Schedule of Events for World Standards Week 2018

Retrieved on: 
Monday, April 23, 2018
Standards, Evaluation, Product testing, Standardization, American National Standards Institute, Conformance testing, Technology, Methodology

NEW YORK, April 23, 2018 /PRNewswire-USNewswire/ --The American National Standards Institute (ANSI) has announced the schedule of events for World Standards Week (WSW) 2018, which will be held October 1519 in Washington, DC.

Key Points: 
  • NEW YORK, April 23, 2018 /PRNewswire-USNewswire/ --The American National Standards Institute (ANSI) has announced the schedule of events for World Standards Week (WSW) 2018, which will be held October 1519 in Washington, DC.
  • Registration is open for WSW, an annual event where members of the standards and conformity assessment community come together in the spirit of cooperation and collaboration.
  • Sponsorship opportunities are also available at a variety of levels for companies and organizations wishing to show their valuable support for the voluntary standardization community.
  • The schedule for WSW 2018 is as follows:

Hospital Technology is the New Determiner of Patient Satisfaction, 2018 Black Book EHR User Survey Results

Retrieved on: 
Friday, April 20, 2018
Health, Medicine, Patient, Healthcare quality, Electronic health records, Patient satisfaction, Product testing

The insight is revealed within the eighth annual Black Book industry surveys of inpatient EHR users including hospital staff, managers, networked physicians and patient panels.

Key Points: 
  • The insight is revealed within the eighth annual Black Book industry surveys of inpatient EHR users including hospital staff, managers, networked physicians and patient panels.
  • "Involvement with healthcare consumers through technologies is proving to be a significant element of patient satisfaction," said Doug Brown, managing partner of Black Book Research.
  • "Healthcare consumers more frequently interact through electronic media in 2018, and while they value contact with their providers, they don't have the patience for lacks in hospital interoperability, incorrect billing and access to scheduling and results."
  • The largest user opinion poll of its kind inhealthcareIT, BlackBookcollects over 57,000 viewpoints on information technology and outsourced services vendor performance annually.

Blood Disorders Pipeline Database 2018 by Indication, Clinical Trial Stages, Drug Mechanism Classes & Company

Retrieved on: 
Wednesday, April 18, 2018
Health, Clinical research, Design of experiments, Medical research, Food and Drug Administration, Clinical trial, Pharmaceutical industry, Product testing, Phases of clinical research, Biotie Therapies, Plexxikon

Blood Disorders Pipeline Highlights Database - 2018, provides most up-to-date information on key pipeline products in the global Blood Disorders Drug market.

Key Points: 
  • Blood Disorders Pipeline Highlights Database - 2018, provides most up-to-date information on key pipeline products in the global Blood Disorders Drug market.
  • It covers emerging therapies for Blood Disorders in active clinical development stages including early and late stage clinical trials.
  • The database provides Blood Disorders pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
  • The database provides Blood Disorders pipeline products by their dominant drug mechanism class.

Lifestyle Delivery Systems Inc. announces Update on Trade Marks and Patent

Retrieved on: 
Wednesday, April 18, 2018
Health, Drug discovery, Clinical trial, Design of experiments, Nursing research, Pharmaceutical industry, Product testing

The Company is scheduling clinical trials in May 2018 to define the bio-availability benefits of the Lifestyle Delivery Systems' CannaStripsTM technology.

Key Points: 
  • The Company is scheduling clinical trials in May 2018 to define the bio-availability benefits of the Lifestyle Delivery Systems' CannaStripsTM technology.
  • These clinical trials are intended to quantify the enhanced delivery method of CannaStripsTM vs other forms of delivery.
  • About Lifestyle Delivery Systems Inc.
    Lifestyle Delivery Systems Inc. is a licensed, state-compliant vertically integrated cannabis-related company.
  • On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Eyes on the Prize: Catalano Design on Streamlined Product Development

Retrieved on: 
Wednesday, April 18, 2018
Product management, Design, Innovation, Human behavior, Creativity, Product development, Product testing, Catalano, Industrial design

Physical design elements such as the super-comfortable ergonomic suspended headband and distinct "Windowshade" grill that minimizes sound reflection are the result of HIFIMAN's work over many years with industrial design firm Catalano Design.

Key Points: 
  • Physical design elements such as the super-comfortable ergonomic suspended headband and distinct "Windowshade" grill that minimizes sound reflection are the result of HIFIMAN's work over many years with industrial design firm Catalano Design.
  • This week on its website, Catalano highlights its work with HIFIMAN to illustrate the lasting impact design guidelines can have on a company.
  • During Catalano's very first projects with HIFIMAN - logo development and design of the HE1000 headphone - Catalano established design guidelines for work with HIFIMAN, which resulted in solutions that have become HIFIMAN design assets and details that have been adapted to subsequent products including the Susvara.
  • Founded in 1987, Catalano Design is an award-winning, full-service product design and development firm located in Boston, MA.

2018 Global Central Nervous System Disorders Pipeline Database: Indication, Clinical Trial Phase, Drug Mechanism Classes & Companies

Retrieved on: 
Tuesday, April 17, 2018
Health, Clinical research, Design of experiments, Medical research, Clinical trial, Drug discovery, Pharmaceutical industry, Product testing, Phases of clinical research, Biotie Therapies, TopoTarget

The "Central Nervous System Disorders Pipeline Database - 2018" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Central Nervous System Disorders Pipeline Database - 2018" report has been added to ResearchAndMarkets.com's offering.
  • It covers emerging therapies for CNS indications in active clinical development stages including early and late stage clinical trials.
  • The database provides CNS disorders pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
  • The database provides CNS disorders pipeline products by their dominant drug mechanism class.